• High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

  • 2024/03/25
  • 再生時間: 14 分
  • ポッドキャスト

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

  • サマリー

  • Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.

    Related Content:

    • High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD.

Related Content:

  • High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。